Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01334736 · ClinicalTrials.gov registry record · NA
A Study of Novel Smoking Cessation Interventions in Current and Former Injection Drug Users
A NA study of Tobacco Dependence, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT01334736: Completed NA study of Tobacco Dependence, sponsored by Johns Hopkins University.
NCT01334736 is a NA study of Tobacco Dependence that has completed, run by Johns Hopkins University. The registered enrollment target is 100 participants, below the 475-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01334736, a NA study of Tobacco Dependence, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Cigarette smoking is very common in current and former injection drug users and is known to cause chronic lung diseases. Quitting smoking is proven to improve the health of people addicted to cigarettes. . Little information exists regarding the perceptions and characteristics of drug users regarding quitting smoking. Additionally, most programs designed to help people quit smoking are not very successful. One reason these programs may not work well is because it is difficult to motivate people to quit smoking. New methods of motivating changes in behavior include small monetary payments for healthy behavior and reporting breathing tests with the concept of "lung age," which is the age of an average healthy person with similar breathing test results. For example, a health care provider can report results as "Although you are 50 years old, you have the lungs for a 70 year old". In this proposal, the investigators plan to first explore the beliefs and characteristics of current and former injection drug users and how they are related to quitting smoking. The investigators then plan to study whether the use of two new methods of motivation increases the chances that this group will stop smoking.
Primary Outcome
The primary outcome will be validated tobacco cessation at 6 months. Biologically confirmed tobacco cessation will be assessed by self-report of smoking status combined with CO measurement.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management
- BEHAVIORAL Usual care
- BEHAVIORAL Lung age
- BEHAVIORAL Lung age + Contingency Management
Study Locations (1)
Maryland
- Johns Hopkins ALIVE Clinic - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-04 |
| Est. Completion | 2012-07 |
| Phase | NA |
What the finished NCT01334736 record still lists
NCT01334736 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 475-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Tobacco Dependence appearing as the primary indexed condition, and to 4 interventions - of which Contingency Management is the first listed.
NCT01334736 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01334736 about?
NCT01334736 is a clinical study titled "A Study of Novel Smoking Cessation Interventions in Current and Former Injection Drug Users". Cigarette smoking is very common in current and former injection drug users and is known to cause chronic lung diseases. Quitting smoking is proven to improve the health of people addicted to cigarettes. . Little information exists regarding the perceptions and characteristics of drug users regardin...
What is the current status of trial NCT01334736?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2011-04. Estimated completion is 2012-07.
What conditions does trial NCT01334736 study?
This clinical trial studies the following conditions: Tobacco Dependence.
What interventions are being tested in trial NCT01334736?
The interventions under investigation include: Contingency Management (BEHAVIORAL), Usual care (BEHAVIORAL), Lung age (BEHAVIORAL), Lung age + Contingency Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT01334736?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01334736 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01334736's enrollment target sits among peer trials
100 23rd of 28 higher than 6 of 28 other Tobacco Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harm Reduction for Smokers With Mental Illness
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers
RECRUITING · NA
-
Use of Nicotine Pouches Among Daily Smokers
RECRUITING · NA
-
Smoke-free Home Study in Subsidized Housing
RECRUITING · NA
-
Assessment of Biomarkers in Children to Help Parents Quit Tobacco
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia